Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
mg or placebo in 2019. 15 Also, a systematic review (2019) of 50,452 diabetes patients did not show a statistically significant increase of the overall cancer risk (OR 1.04; 95% CI: 0.94 4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c.
Let's personalize your content